Literature DB >> 7295547

Haematological changes following systemic injection of purified carrageenans (kappa, lambda and iota).

R J Davidson, J G Simpson, P H Whiting, J I Milton, A W Thomson.   

Abstract

Kappa, lambda and iota carrageenans were administered i.p. (125 mg/kg) to groups of Sprague-Dawley rats. Each carrageenan (but especially kappa and lambda) caused thrombocytopenia and red-cell damage, particularly burring, within 2 days. This was followed by rebound thrombocytosis and persistent anaemia, accompanied by a reticulocytosis. A 2-fold increase in fibrinogen was observed at 24 or 48 h. All groups showed a leucopenia at 1 h, then a progressive leucocytosis, maximal at 48 h (kappa and lambda) or Day 7 (iota). Between 1 and 24 h there was a significant lymphopenia, followed by lymphocytosis (kappa and lambda) including Turk cells and pronounced neutrophilia in all groups. Monocytosis occurred in response to each carrageenan on Days 2-4 (kappa) or Day 7 (lambda and iota). Injection of kappa carrageenan was characterized by the presence (up to Day 7) of carrageenan-positive material, in the form of floccules, within the peripheral blood, and by Day 7 the appearance of histiocyte-type macrophages which exhibited haemo-phagocytosis. In the lambda group, carrageenan-positive granules were observed in the cytoplasm of mononuclear cells throughout the experimental period. No intracellular carrageenan was demonstrable in peripheral blood in the iota group or within neutrophils of any of the injected animals. Overall marrow cellularity was not altered by carrageenan, but small numbers of kappa- and lambda-containing macrophages were identified. Splenomegaly was consistently observed and in histological section carrageenan-positive macrophages were detected in the red pulp, particularly in the lambda group.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7295547      PMCID: PMC2041705     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  22 in total

1.  Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs.

Authors:  C A WINTER; E A RISLEY; G W NUSS
Journal:  Proc Soc Exp Biol Med       Date:  1962-12

2.  Suppression of primary immunization by carrageenan - a macrophage toxic agent.

Authors:  D E Bice; D G Gruwell; J E Salvaggio; E O Hoffmann
Journal:  Immunol Commun       Date:  1972

Review 3.  Biological properties of carrageenan.

Authors:  M Di Rosa
Journal:  J Pharm Pharmacol       Date:  1972-02       Impact factor: 3.765

4.  Lymphocytosis produced by heparin and other sulphated polysaccharides in mice and rats.

Authors:  J W Bradfield; G V Born
Journal:  Cell Immunol       Date:  1974-10       Impact factor: 4.868

5.  Interaction of degraded iota carrageenans with plasma membranes: sedimentation of erythrocytes of different species.

Authors:  E P Pittz; L Golberg; F Coulston
Journal:  Life Sci       Date:  1975-09-15       Impact factor: 5.037

6.  An evaluation of the heat precipitation method for plasma fibrinogen estimation.

Authors:  H R Millar; J G Simpson; A L Stalker
Journal:  J Clin Pathol       Date:  1971-12       Impact factor: 3.411

7.  Evaluation of carrageenan as an immunosuppressive agent and mediator of intravascular coagulation.

Authors:  A W Thomson; A R Wilson; W J Cruickshank; C H Horne
Journal:  Biomedicine       Date:  1976-05

8.  Toxicity of various carrageenans in the mouse.

Authors:  A W Thomson; C H Horne
Journal:  Br J Exp Pathol       Date:  1976-08

9.  Spectrum and possible mechanism of carrageenan cytotoxicity.

Authors:  P J Catanzaro; H J Schwartz; R C Graham
Journal:  Am J Pathol       Date:  1971-08       Impact factor: 4.307

10.  An examination of the cytotoxic effects of silica on macrophages.

Authors:  A C Allison; J S Harington; M Birbeck
Journal:  J Exp Med       Date:  1966-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.